A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

[1]  C. Mackenzie,et al.  Assessing illness severity: does clinical judgment work? , 1986, Journal of chronic diseases.

[2]  M. Charlson,et al.  Applying results of randomised trials to clinical practice: impact of losses before randomisation. , 1984, British medical journal.

[3]  Rate of disease progression in breast cancer: a clinical estimate of prognosis within nodal and anatomic stages. , 1984, Journal of the National Cancer Institute.

[4]  T. Hutchinson,et al.  Predicting survival in adults with end-stage renal disease: an age equivalence index. , 1982, Annals of internal medicine.

[5]  D. Sackett,et al.  Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.

[6]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.

[7]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[8]  A. Feinstein,et al.  The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.

[9]  D. Cox.  Regression Models and Life-Tables , 1972 .

[10]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.

[11]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.